Flow-diverting stent and delayed intracranial bleeding: the case for discussing acquired von Willebrand disease. (3rd April 2021)

• Record Type: Journal Article
• Authors: Oran, Ismail
• Is Part Of: Platelets. Volume 32:Number 3(2021)
• Page Start: 432
• Page End: 435
• Publication Date: 2021-04-03
• Subjects: Cerebral aneurysm -- flow diverting stent -- von Willebrand factor; Blood platelets -- Periodicals; Blood Platelets -- Periodicals; 615.39
• DOI: 10.1080/09537104.2020.1754379
• Languages: English
• ISSNs: 0953-7104

Abstract

Abstract: A unique feature of the flow-diverting stent (FDS) has rendered it useful in the endovascular treatment of selected intracranial aneurysms for the last decade. Delayed aneurysmal rupture and intracranial parenchymal bleeding are two leading hemorrhagic complications after FDS. It has recently been shown for the first time that there is a relationship between FDS and reduced level of vWF activity in patients undergoing endovascular cerebral aneurysm treatment. Here, the current literature is reviewed in the context of this novel finding to propose an illustrative scenario that conceptually links implantation of FDS to delayed intracranial bleeding, through the mechanism of shear-induced activation of vWF. In this scenario, after FDS implantation, sustained release of activated vWF in association with platelets plays a pivotal role in the mechanisms of delayed intracranial hemorrhages.